Literature DB >> 23716202

c-Rel is an essential transcription factor for the development of acute graft-versus-host disease in mice.

Yu Yu1, Dapeng Wang, Kane Kaosaard, Chen Liu, Jianing Fu, Kelley Haarberg, Claudio Anasetti, Amer A Beg, Xue-Zhong Yu.   

Abstract

Transcription factors of the Rel/NF-κB family are known to play different roles in immunity and inflammation, although the putative role of c-Rel in transplant tolerance and graft-versus-host disease (GVHD) remains elusive. We report here that T cells deficient for c-Rel have a dramatically reduced ability to cause acute GVHD after allogeneic bone marrow transplantation using major and minor histocompatibility mismatched murine models. In the study to understand the underlying mechanisms, we found that c-Rel(-/-) T cells had a reduced ability to expand in lymphoid organs and to infiltrate in GVHD target organs in allogeneic recipients. c-Rel(-/-) T cells were defective in the differentiation into Th1 cells after encountering alloantigens, but were enhanced in the differentiation toward Foxp3(+) regulatory T (Treg) cells. Furthermore, c-Rel(-/-) T cells had largely preserved activity to mediate graft-versus-leukemia response. Taken together, our findings indicate that c-Rel plays an essential role in T cells in the induction of acute GVHD, and suggest that c-Rel can be a potential target for therapeutic intervention in allogeneic hematopoietic cell transplantation in the clinic.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Bone marrow transplantation; Graft-versus-host disease (GVHD); c-Rel

Mesh:

Substances:

Year:  2013        PMID: 23716202      PMCID: PMC3940138          DOI: 10.1002/eji.201243282

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  49 in total

Review 1.  A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease.

Authors:  Robert Sackstein
Journal:  Biol Blood Marrow Transplant       Date:  2006-01       Impact factor: 5.742

2.  Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice.

Authors:  Yu Yu; Dapeng Wang; Chen Liu; Kane Kaosaard; Kenrick Semple; Claudio Anasetti; Xue-Zhong Yu
Journal:  Blood       Date:  2011-08-19       Impact factor: 22.113

3.  Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

Authors:  Kathrin Rieger; Christoph Loddenkemper; Jochem Maul; Thomas Fietz; Daniel Wolff; Harald Terpe; Beate Steiner; Erika Berg; Stephan Miehlke; Martin Bornhäuser; Thomas Schneider; Martin Zeitz; Harald Stein; Eckhard Thiel; Rainer Duchmann; Lutz Uharek
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

4.  NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145.

Authors:  Sanja Vodanovic-Jankovic; Parameswaran Hari; Paulette Jacobs; Richard Komorowski; William R Drobyski
Journal:  Blood       Date:  2005-09-20       Impact factor: 22.113

5.  Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

Authors:  Emmanuel Zorn; Haesook T Kim; Stephanie J Lee; Blair H Floyd; Despina Litsa; Sankari Arumugarajah; Roberto Bellucci; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

6.  Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.

Authors:  Yasunari Morimoto; Yang Bian; Ping Gao; Yumi Yashiro-Ohtani; Xu-Yu Zhou; Shiro Ono; Hirokazu Nakahara; Mikihiko Kogo; Toshiyuki Hamaoka; Hiromi Fujiwara
Journal:  J Leukoc Biol       Date:  2005-09       Impact factor: 4.962

7.  Natural regulation of immunity to minor histocompatibility antigens.

Authors:  Nathan J Robertson; Jian-Guo Chai; Maggie Millrain; Diane Scott; Fazila Hashim; Emily Manktelow; François Lemonnier; Elizabeth Simpson; Julian Dyson
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

8.  In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.

Authors:  Michael J Carlson; Michelle L West; James M Coghill; Angela Panoskaltsis-Mortari; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2008-10-28       Impact factor: 22.113

9.  Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.

Authors:  Yaming Liang; Chen Liu; Julie Y Djeu; Bin Zhong; Thorsten Peters; Karin Scharffetter-Kochanek; Claudio Anasetti; Xue-Zhong Yu
Journal:  Blood       Date:  2007-10-10       Impact factor: 22.113

10.  IL-17 contributes to CD4-mediated graft-versus-host disease.

Authors:  Lucy W Kappel; Gabrielle L Goldberg; Christopher G King; David Y Suh; Odette M Smith; Cassandra Ligh; Amanda M Holland; Jeremy Grubin; Nicholas M Mark; Chen Liu; Yoichiro Iwakura; Glenn Heller; Marcel R M van den Brink
Journal:  Blood       Date:  2008-10-17       Impact factor: 22.113

View more
  12 in total

1.  T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.

Authors:  Jianing Fu; Yongxia Wu; Hung Nguyen; Jessica Heinrichs; Steven Schutt; Yuejun Liu; Chen Liu; Junfei Jin; Claudio Anasetti; Xue-Zhong Yu
Journal:  J Immunol       Date:  2016-02-22       Impact factor: 5.422

2.  T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function.

Authors:  Jianing Fu; Dapeng Wang; Yu Yu; Jessica Heinrichs; Yongxia Wu; Steven Schutt; Kane Kaosaard; Chen Liu; Kelley Haarberg; David Bastian; Daniel G McDonald; Claudio Anasetti; Xue-Zhong Yu
Journal:  J Immunol       Date:  2014-11-17       Impact factor: 5.422

3.  Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.

Authors:  M Hanief Sofi; Yongxia Wu; Steven D Schutt; Min Dai; Anusara Daenthanasanmak; Jessica Heinrichs Voss; Hung Nguyen; David Bastian; Supinya Iamsawat; Shanmugam Panneer Selvam; Chen Liu; Nilanjana Maulik; Besim Ogretmen; Junfei Jin; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2019-05-02       Impact factor: 14.808

4.  Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model.

Authors:  Jing Yuan; Han-yun Ren; Yong-jin Shi; Wei Liu
Journal:  Inflamm Res       Date:  2015-01-04       Impact factor: 4.575

5.  A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity.

Authors:  Yusuke Shono; Andrea Z Tuckett; Samedy Ouk; Hsiou-Chi Liou; Grégoire Altan-Bonnet; Jennifer J Tsai; Jennifer E Oyler; Odette M Smith; Mallory L West; Natalie V Singer; Ekaterina Doubrovina; Dmitry Pankov; Chandresh V Undhad; George F Murphy; Cecilia Lezcano; Chen Liu; Richard J O'Reilly; Marcel R M van den Brink; Johannes L Zakrzewski
Journal:  Cancer Discov       Date:  2014-02-18       Impact factor: 39.397

6.  Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses.

Authors:  Yusuke Shono; Andrea Z Tuckett; Hsiou-Chi Liou; Ekaterina Doubrovina; Enrico Derenzini; Samedy Ouk; Jennifer J Tsai; Odette M Smith; Emily R Levy; Fabiana M Kreines; Carly G K Ziegler; Mary I Scallion; Mikhail Doubrovin; Glenn Heller; Anas Younes; Richard J O'Reilly; Marcel R M van den Brink; Johannes L Zakrzewski
Journal:  Cancer Res       Date:  2016-01-07       Impact factor: 12.701

7.  c-Rel in GVHD biology: a missing link.

Authors:  Shoba Amarnath
Journal:  Eur J Immunol       Date:  2013-09       Impact factor: 5.532

Review 8.  c-Rel and its many roles in cancer: an old story with new twists.

Authors:  Jill E Hunter; Jack Leslie; Neil D Perkins
Journal:  Br J Cancer       Date:  2016-01-12       Impact factor: 7.640

9.  Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice.

Authors:  Steven D Schutt; Jianing Fu; Hung Nguyen; David Bastian; Jessica Heinrichs; Yongxia Wu; Chen Liu; Daniel G McDonald; Joseph Pidala; Xue-Zhong Yu
Journal:  PLoS One       Date:  2015-09-08       Impact factor: 3.240

10.  Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.

Authors:  Ling Li; Zijun Y Xu-Monette; Chi Young Ok; Alexandar Tzankov; Ganiraju C Manyam; Ruifang Sun; Carlo Visco; Mingzhi Zhang; Santiago Montes-Moreno; Karen Dybkaer; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Michael B Møller; Jinfen Wang; Ben M Parsons; Jane N Winter; Miguel A Piris; Lan V Pham; L Jeffrey Medeiros; Ken H Young
Journal:  Oncotarget       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.